Health Condition 1: D619- Aplastic anemia, unspecified Health Condition 2: Z946- Bone transplant status Health Condition 3: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Advanced Centre for Treatment Research and Education in Cancer)
Eligibility
Inclusion criteria
Inclusion criteria: -Patients who underwent transplant autologous or allogeneic at ACTREC between 1st July 2007 and 30th June 2013 -Malignant hematological disorders and aplastic anemia -Survived for more than 2 years with or without relapse of underlying disease -Willing to provide an informed consent
Exclusion criteria
Exclusion criteria: Multiple myeloma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of chronic health conditions Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| -Incidence and cause of mortality -Assessment of functional status and fertility -Assessment of quality of life (QoL) -Comparison of chronic health conditions, functional status, fertility and QoL between survivors of autologous and allogeneic BMT Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Bishal Sharma
Advanced Centre for Treatment Research and Education in Cancer
Outcome results
None listed